Ohio’s Automated Rx Reporting System (OARRS) can help physicians improve patient care, reduce prescription abuse, and prescribe safely.
- Provide better patient care
- Identify patients with potential drug seeking behaviors
- Ensure that the patient’s drug therapy is appropriate
- Comply with “press pause” clinical guidelines at 80 morphine equivalent dose (MED)
- Demonstrate the effectiveness of clinical guidelines making adoption of prescribing rules unnecessary.
House Bill 341 of the 130th Ohio General Assembly mandates the use of OARRS prior to prescribing an opioid analgesic or benzodiazepine. The law also includes OARRS registration requirements for both prescribers and pharmacists.
Beginning January 1, 2015, Ohio law requires that each prescriber who prescribes or personally furnishes opioid analgesics or benzodiazepines, as well as all pharmacists who dispense or plan to dispense controlled substances within the state of Ohio, certify to their respective licensing board that they have registered for an OARRS account upon renewing their license.
- Before initially prescribing or personally furnishing an opioid analgesic or a benzodiazepine to a patient, the prescriber must request patient information from OARRS that covers at least the previous 12 months.
- The prescriber must also make periodic requests for patient information from OARRS if the course of treatment continues for more than 90 days.
- Under the circumstances described above, the prescriber is required to assess the OARRS information and document in the patient record that a patient prescription history report was received and assessed.
In order to continue to assist the health care community in implementing the new laws, the Ohio State Board of Pharmacy has updated its frequently asked questions document that also reflects a March 20, 2015, change in Ohio law pertaining to including the OARRS report in patient medical records.
Additional Information and Resources
- New Feature Added to OARRS Making It Easier for Prescribers to Identify Compliance Issues (Weekly Family Medicine Update, January 5, 2017)
- OAFP Meets with Pharmacy and Medical Boards about OARRS Compliance (Weekly Family Medicine Update, December 13, 2016)
- OARRS Compliance Update (Weekly Family Medicine Update, December 6, 2016)
- Reporting Gabapentin Products to OARRS (Weekly Family Medicine Update, December 6, 2016)
- Physician Associations Request Meeting with Pharmacy Board about OARRS Reports (Weekly Family Medicine Update, November 29, 2016)
- State Medical Board Sends another Round of Email Threats about OARRS (Weekly Family Medicine Update, November 8, 2016)
- State Medical Board Threatens 12,000 Physicians with Being OARRS Non-Compliant (Weekly Family Medicine Update, October 18, 2016)
- Reporting Gabapentin Products to OARRS (Weekly Family Medicine Update, August 23, 2016)
- Opioid Doses, Prescriptions for Ohio Patients Continue to Decrease: OARRS Report Shows Sustained Progress in 2015 (Weekly Family Medicine Update, February 16, 2016)
- OARRS Report as Part of Patient Record (Weekly Family Medicine Update, January 19, 2016)
Integrating OARRS into EHR Systems (Weekly Family Medicine Update, October 27, 2015)
Ohio Automated Rx Reporting System Website Gets an Updated Look and New Features (Weekly Family Medicine Update, October 20, 2015)
Practice Insight Report Now Available in OARRS (Weekly Family Medicine Update, May 5, 2015)
Veterans Health Administration Now Reporting to the Ohio Automated Rx Reporting System (Weekly Family Medicine Update, April 28, 2015)
- 2013-14 OARRS Biennial Report (January 2015)
- OARRS Change Addresses Neonatal Abstinence Syndrome in Ohio Newborns (Weekly Family Medicine Update, July 8, 2014)